What’s more, AREG, STAG3, C19orf57 and CAV1 are key prognostic biomarkers for HPV-negative HNSCC, they may also be potential therapeutic targets, drugs targeting the four key genes either alone or in combination may be new strategies for the treatment of HNSCC in further investigations. Here, CAV1 is linked to head and neck squamous cell carcinoma.